Biohit ColonView Hb/Hp Test Instructions D'utilisation page 80

REFERENCES / VIITTEET / REFERENSER/ REFERENZEN
/REFERENCES / BIBLIOGRAFIA / REFERENCIAS
1. Lieberman D. Screening/Early Detection Model for Colorectal
Cancer, Why Screen? Cancer Supplement 1994; 74(7): 2023-
2027.
2. Morbidity and Mortality Weekly Report; (2007) 56(10): 227-228.
3. Dam, JV et. Al. Fecal Blood Screening for Colorectal Cancer.
Archive of Internal Medicine 1995;155:2389-2402
4. Miller AB. An Epidemiological Perspective on Cancer Screening.
Clinical Biochemistry 1995; 28(1): 41-48.
5. Ransohoff DF and Lang CA. Improving the Fecal Occult- Blood
Test. The New England Journal of Medicine 1996; 334 (3): 189-
190.
6. Frommer DJet al. Improved Screening for Colorectal Cancer by
Immunological Detection of Occult Blood. British Medical Journal
1988; 296:1092-1094
7. St. John DJB et al. Evaluation of New Occult Blood Test for
Detection of ColorectalNeoplasia. Gastroenterology 1993;
104:1661-1668
8. Lüthgens K et al. Hemoglobin-Haptoglobin Complex: A Highly
Sensitive Assay for the Detection of Fecal Occult Blood. Clinical
Laboratory 1998; 44: 543-551.
9. Sieg A et al. Detection of colorectal neoplasms by the highly sen-
sitive hemoglobin-haptoglobin complex in feces. International
Journal of Colorectal Disease 1999; 14: 267-271.
10.van Rossum L et al.Random comparison of guaiac and immuno-
chemical fecal occult blood tests for colorectal cancer in scree-
ning population. Gastroenterology 2008; 135: 82-90.
11.Yamamoto M.; Nakama H.; Cost-effectiveness analysis of immu-
nochemical occult blood screening for colorectal cancer among
three fecal sampling methods : Hepatogastroenterology; 2000
Mar-Apr; 47(32):396-9.
80